BCL2 Expression at Post-Induction and Complete Remission Impact Outcome in Acute Myeloid Leukemia

Advances in acute myeloid leukemia (AML) genomics and targeted therapies include the recently approved BCL2 inhibitor venetoclax. The association between BCL2 expression and patient outcome was analyzed in a series of 176 consecutive AML patients at diagnosis (Dx), post-induction (PI), complete remi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diagnostics (Basel)
Main Authors: Bilbao-Sieyro, Cristina, Rodríguez-Medina, Carlos, Florido, Yanira, Stuckey, Ruth, Sáez, María Nieves, Sánchez-Sosa, Santiago, González Martín, Jesús María, Santana, Guillermo, González-Pérez, Elena, Cruz-Cruz, Naylén, Fernández, Rosa, Molero Labarta, Teresa, Gomez-Casares, María Teresa
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7762084/
https://ncbi.nlm.nih.gov/pubmed/33291851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10121048
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker